Seal Shield LLC, a prominent healthcare technology firm specializing in solutions for infection control, is excited to announce its collaboration with Leapfrog Group, a nationwide nonprofit organization committed to advancing the quality and safety of healthcare in the United States. The partnership between Seal Shield and Leapfrog Group represents a significant stride in healthcare excellence, as both entities share a common vision for patient safety and innovative solutions.

Central to Leapfrog Group's endeavors are two flagship initiatives: the Leapfrog Hospital Survey and the Leapfrog Hospital Safety Grade. These initiatives collect and openly report hospital performance data, empowering patients and healthcare buyers with crucial insights to make well-informed decisions. By assigning letter grades to hospitals based on their track record of patient safety, Leapfrog Group aims to safeguard consumers from errors, injuries, accidents, and infections.

Seal Shield, renowned for its pioneering work in infection control technology, will contribute its expertise to address the urgent need for reducing hospital-acquired infections. This partnership revolves around a shared mission to elevate patient outcomes and curtail the transmission of harmful pathogens within healthcare environments.

A key influencer in this collaboration is Dr. Norman Horn, Lead Chemical Engineer at Seal Shield. With a profound background in Chemical Engineering and specialized knowledge in UV-C Technology and infection control, Dr. Horn is a respected authority in his field. His innovative contributions have earned him accolades and published works in esteemed peer-reviewed journals across various domains.

In the pursuit of elevating patient safety, Dr. Horn, in conjunction with Seal Shield's CEO, Brad Whitchurch, will actively engage in the Work Group on the Environment of Care in Hospitals and Ambulatory Surgery Centers. This group is dedicated to assessing the risk of biocontamination on diverse surfaces, including both rigid and soft surfaces, air, and interfaces between water and hard surfaces. Collaboratively, the group will formulate a recommended framework for managing the care environment in hospitals and ASCs.

Additionally, Seal Shield will participate in the highly anticipated Leapfrog Annual Conference in Washington, DC, scheduled for December. The conference will revolve around pertinent subjects, challenges, and trends in healthcare procurement, benefits, safety, quality, and value.

"Seal Shield remains committed to introducing groundbreaking solutions that redefine patient safety in healthcare," remarked CEO Brad Whitchurch. "Our partnership with Leapfrog signifies a remarkable stride towards establishing a healthier and safer setting for patients, healthcare practitioners, and the entire healthcare community."

Seal Shield's unwavering dedication to patient safety is further highlighted by their continuous innovation and collaboration in infection control technology. Most recently, the company expanded its product range through the acquisition of Clean Slate UV, a frontrunner in UV-C technology that enables healthcare professionals to disinfect hard-to-clean devices.

 

Source: prnewswire.com

Report Abuse